Caricamento...
Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of success from a randomized trial
BACKGROUND: Early pregnancy loss (EPL) is a common event in the first trimester, occurring in 15–20% of recognized pregnancies. A common evidence-based medical regimen for EPL management uses the prostaglandin E1 analogue misoprostol 800 mcg self-administered vaginally. The clinical utility of this...
Salvato in:
| Pubblicato in: | Am J Obstet Gynecol |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7529708/ https://ncbi.nlm.nih.gov/pubmed/32305259 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2020.04.006 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|